Cortisol Metabolism in Human Obesity: Impaired Cortisone→Cortisol Conversion in Subjects with Central Adiposity1
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
For a given body mass index (BMI), mortality is higher in patients with central compared to generalized obesity. Glucocorticoids play an important role in determining body fat distribution, but circulating cortisol concentrations are reported to be normal in obese patients. Our recent studies show enhanced conversion of inactive cortisone (E) to active cortisol (F) through the expression of 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in cultured omental adipose stromal cells; the autocrine production of F may be a crucial factor in the pathogenesis of central obesity. We have now analyzed F metabolism in subjects with BMIs between 20-25 kg/m2 (group A), 25-30 kg/m2 (group B), and more than 30 kg/m2 (group C; n 12 in each group; six males and six premenopausal females; aged 23-44 yr). Glucose/insulin were measured using a 75-g oral glucose tolerance test, and each subject had total body and regional fat (scapular, waist, hip, and thigh) quantified using dual energy x-ray absorptiometry. Urinary total F metabolites (measured by gas chromatography/mass spectrometry) were increased in subjects with obesity [group A, 11,176 +/- 1,530 microg/24 h (mean +/- SE); group C, 13,661 +/- 1,444], although not significantly so (P = 0.08). There was a significant reduction in the urinary tetrahydrocortisol (THF) +/- 5alpha-THF/tetrahydrocortisone (THE) and the cortol/cortolone ratio in obesity (group A vs. C, 1.06 +/- 0.08 vs. 0.84 +/- 0.04 and 0.41 +/- 0.03 vs. 0.34 +/- 0.03, respectively; both P < 0.05). Urinary free F (UFF) excretion was similar in all three groups, as was the UFF/urinary free E (UFE) ratio. The 0900 h circulating F, E, and ACTH pre- and postovernight 1-mg dexamethasone suppression values were similar in all three groups, but a reduction in the generation of serum F from dexamethasone-suppressed values after oral cortisone acetate (25 mg) was evident in both obese groups [e.g. 546 +/- 37 nmol/L in group A vs. 412 +/- 40 in group B (P < 0.05) and 388 +/- 38 in group C (P < 0.01) 180 min post-E]. Insulin resistance was present in groups B and C, but regression analysis revealed no relationship between F metabolites or the THF +/- 5alpha-THF/THE ratio and insulin action (homeostasis model assessment analysis and insulin values in the oral glucose tolerance test). There was, however, a highly significant relationship between the THF +/- 5alpha-THF/THE ratio and BMI (t = -3.44; P < 0.01) and total body fat (t = -2.27; P < 0.05). Stepwise regression analyses indicated an inverse relationship between THF+/-5alpha-THF/THE and scapular and waist fat (t = -2.25; P = 0.03) and a direct relationship with hip and thigh fat (t = 2.42; P = 0.02) in both sexes. The fall in the THF + 5alpha-THF/THE ratio but unchanged UFF/UFE ratio together with impaired F concentrations after oral E indicates inhibition of 11betaHSD1 in subjects with obesity. This results in an increased MCR for F, explaining the increased F secretion rate in obesity in the face of normal circulating F concentrations. 11BetaHSD1 activity is highly related to body fat distribution, with android or central obesity, but not gynoid obesity, associated with reduced activity in both sexes. This reduction in 11betaHSD1 activity raises new questions as to the primary role of 11betaHSD1 in the pathogenesis of insulin resistance and central obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As surrogate measures of adverse metabolic risk (27), AVF and omental fat-cell size have been associated in some but not all studies with increased activity or expression of 11β-hydroxysteroid dehydrogenase type 1, which promotes conversion of inactive cortisone to active cortisol (28–31).”
From Glucose ingestion selectively amplifies ACTH and cortisol secretory-burst mass and enhances their joint synchrony in healthy men. (2011) · cites this paper as [31]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 2×
“increased expression of 11bHSD1 in human adipose stromal cells from omental compared with sc depots (21).”
Self-citationSex- and menopause-associated changes in body-fat distribution
Ley, C., Lees, B., & Stevenson, J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.5.950 · Cited by 733
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
(1996) · PubMed · Cited by 643
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Cortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
Self-citation
Cited by
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Metabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565
“In obesity global 11b-HSD1 activity, as measured by urinary corticosteroid metabolite analysis, is impaired [86,87], while selective 11bHSD1 inhibitors, are in development with promising results showing improvements in metabolic profile in rodents [88].”
Method11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“Some studies have described decreased ratios consistent with decreased 11 -HSD1 reductase activity with increasing body mass index (BMI) in simple obesity (140, 203).”
Self-citationSeckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Obesity and polycystic ovary syndrome
Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02587.x · Cited by 631
Power, M. L., & Schulkin, J. (2008) · British Journal of Nutrition · doi:10.1017/s0007114507853347 · Cited by 605
Morton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 439
Incollingo Rodriguez, A. C., Epel, E. S., White, M. L., Standen, E. C., Seckl, J. R., & Tomiyama, A. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.014 · Cited by 422
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392
Rask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385
“In contrast, 11b-HSD1 activity is reduced in the liver in obesity (Stewart et al. 1999, Rask et al. 2001).”
11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
Self-citationLivingstone, D. E. W., Jones, G. C., Smith, K., Jamieson, P. M., Andrew, R., Kenyon, C. J., & Walker, B. R. (2000) · Endocrinology · doi:10.1210/endo.141.2.7297 · Cited by 347
O'Reilly, M. W., Taylor, A. E., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J. W., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 283
Self-citationThe role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
Wang, M. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-3 · Cited by 277
Andrews, R. C., Rooyackers, O., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021194 · Cited by 266
Fat as an Endocrine Organ: Relationship to the Metabolic Syndrome
Hutley, L., & Prins, J. B. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00005 · Cited by 262
The adipocyte as an active participant in energy balance and metabolism
Badman, M. K., & Flier, J. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.058 · Cited by 256
Paulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, M.-C., & Grino, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8614 · Cited by 241
Mah, P. M., Jenkins, R. C., Rostami‐Hodjegan, A., Newell‐Price, J., Doane, A., Ibbotson, V., Tucker, G. T., & Ross, R. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02106.x · Cited by 243
“Changes in cortisol metabolism with increasing BMI have been described (Stewart et al., 1999) and may be a consequence of enhanced A-ring reductase activity as well as decreased 11-beta-hydroxysteroid dehydrogenase type 1 reductase activity.”
BackgroundAbraham, S. B., Rubino, D., Sinaii, N., Ramsey, S., & Nieman, L. K. (2013) · Obesity · doi:10.1002/oby.20083 · Cited by 224
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239
“Moreover, liver 11 -HSD1 is downregulated in obesity, so that the incremental effect of inhibition may be smaller in the obese (Stewart et al., 1999; Rask et al., 2001,2002).”
InfluentialLiquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories
Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Yue, B., Bergquist, J., & Meikle, A. W. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.07.008 · Cited by 228
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., & Salonen, J. T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0970 · Cited by 230
Wake, D. J., Rask, E., Livingstone, D. E. W., Söderberg, S., Olsson, T., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030286 · Cited by 231
Morin-Papunen, L. C., Vauhkonen, I., Koivunen, R. M., Ruokonen, A., & Tapanainen, J. S. (2000) · Human Reproduction · doi:10.1093/humrep/15.6.1266 · Cited by 227
Lindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030017 · Cited by 225
Tomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., & Stewart, P. M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8168 · Cited by 222
Self-citationRegulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight Loss
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Heintze, U., Janke, J., Luft, F. C., & Sharma, A. M. (2004) · Obesity Research · doi:10.1038/oby.2004.3 · Cited by 211
Kannisto, K., Pietiläinen, K. H., Ehrenborg, E., Rissanen, A., Kaprio, J., Hamsten, A., & Yki-Järvinen, H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0153 · Cited by 205
Sandeep, T. C., Andrew, R., Homer, N. Z. M., Andrews, R. C., Smith, K., & Walker, B. R. (2005) · Diabetes · doi:10.2337/diabetes.54.3.872 · Cited by 205
Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance
Andrews, R. C., Herlihy, O., Livingstone, D. E. W., Andrew, R., & Walker, B. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020048 · Cited by 199
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Self-citationDoes altered glucocorticoid homeostasis increase cardiovascular risk?
GIROD, J., & BROTMAN, D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.07.006 · Cited by 193
Goodarzi, M. O., Carmina, E., & Azziz, R. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.06.003 · Cited by 188
Tomlinson, J. W., Sinha, B., Bujalska, I., Hewison, M., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020687 · Cited by 187
Self-citation11β-hydroxysteroid dehydrogenases: changing glucocorticoid action
Seckl, J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.001 · Cited by 185
Larsson, C. A., Gullberg, B., Råstam, L., & Lindblad, U. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-16 · Cited by 174
Rippe, R. C. A., Noppe, G., Windhorst, D. A., Tiemeier, H., van Rossum, E. F. C., Jaddoe, V. W. V., Verhulst, F. C., Bakermans-Kranenburg, M. J., van IJzendoorn, M. H., & van den Akker, E. L. T. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.12.016 · Cited by 176
Cooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Self-citationKokkoris, P., & Pi-Sunyer, F. X. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00078-1 · Cited by 184
Glucocorticoids and non-alcoholic fatty liver disease
Woods, C. P., Hazlehurst, J. M., & Tomlinson, J. W. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.020 · Cited by 171
Cortisol—cause and cure for metabolic syndrome?
Walker, B. R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01998.x · Cited by 179
Westerbacka, J., Yki-Järvinen, H., Vehkavaara, S., Häkkinen, A.-M., Andrew, R., Wake, D. J., Seckl, J. R., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030596 · Cited by 178
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
Mitchell, J. L., Lyons, H. S., Walker, J. K., Yiangou, A., Grech, O., Alimajstorovic, Z., Greig, N. H., Li, Y., Tsermoulas, G., Brock, K., et al. (2023) · Brain · doi:10.1093/brain/awad003 · Cited by 160
Morton, N. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 163
Bujalska, I. J., Draper, N., Michailidou, Z., Tomlinson, J. W., White, P. C., Chapman, K. E., Walker, E. A., & Stewart, P. M. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01718 · Cited by 165
Self-citationInhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Wamil, M., & Seckl, J. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.001 · Cited by 163
Glucose Intolerance in a Large Cohort of Mediterranean Women With Polycystic Ovary Syndrome
Gambineri, A., Pelusi, C., Manicardi, E., Vicennati, V., Cacciari, M., Morselli-Labate, A. M., Pagotto, U., & Pasquali, R. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2353 · Cited by 168
Liquid chromatography–tandem mass spectrometry applications in endocrinology
Kushnir, M. M., Rockwood, A. L., & Bergquist, J. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20264 · Cited by 159
Valsamakis, G., Anwar, A., Tomlinson, J. W., Shackleton, C. H. L., McTernan, P. G., Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032240 · Cited by 160
Self-citationJanssen, J. A. M. J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158178 · Cited by 180
Tsilchorozidou, T., Honour, J. W., & Conway, G. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030240 · Cited by 155
Diederich, S., Eigendorff, E., Burkhardt, P., Quinkler, M., Bumke-Vogt, C., Rochel, M., Seidelmann, D., Esperling, P., Oelkers, W., & Bähr, V. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020970 · Cited by 154
Childhood Obesity and Its Impact on the Development of Adolescent PCOS
Anderson, A., Solorzano, C., & McCartney, C. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371092 · Cited by 146
Tissue Production of Cortisol by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Metabolic Disease
WALKER, B. R., & ANDREW, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.012 · Cited by 150
Vicennati, V. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4093 · Cited by 146
Diagnosis and differential diagnosis of Cushing’s syndrome
Findling, J. W., & Raff, H. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70209-7 · Cited by 147
Increased Cortisol Bioavailability, Abdominal Obesity, and the Metabolic Syndrome in Obese Women
Duclos, M., Pereira, P. M., Barat, P., Gatta, B., & Roger, P. (2005) · Obesity Research · doi:10.1038/oby.2005.137 · Cited by 146
Resistance to Glucocorticoid Feedback in Obesity
Jessop, D. S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4109 · Cited by 141
Pasquali, R., Ambrosi, B., Armanini, D., Cavagnini, F., Uberti, E. C. D., Rio, G. D., Pergola, G. D., Maccario, M., Mantero, F., Marugo, M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.166 · Cited by 141
Seckl, J. R., & Walker, B. R. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.09.007 · Cited by 154
The adrenal and polycystic ovary syndrome
Yıldız, B. O., & Azziz, R. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9054-0 · Cited by 149
Watts, L. M., Manchem, V. P., Leedom, T. A., Rivard, A. L., McKay, R. A., Bao, D., Neroladakis, T., Monia, B. P., Bodenmiller, D. M., Cao, J. X.-C., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1846 · Cited by 137
11β‐HSD Type 1 Expression in Human Adipose Tissue: Impact of Gender, Obesity, and Fat Localization
Paulsen, S. K., Pedersen, S. B., Fisker, S., & Richelsen, B. (2007) · Obesity · doi:10.1038/oby.2007.233 · Cited by 136
Glucocorticoid Metabolism in Obesity and Following Weight Loss
Akalestou, E., Genser, L., & Rutter, G. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00059 · Cited by 143
Cortisol Release From Adipose Tissue by 11β-Hydroxysteroid Dehydrogenase Type 1 in Humans
Stimson, R. H., Andersson, J., Andrew, R., Redhead, D. N., Karpe, F., Hayes, P. C., Olsson, T., & Walker, B. R. (2009) · Diabetes · doi:10.2337/db08-0969 · Cited by 128
11&Bgr;-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Morton, N. M., & Seckl, J. R. (2008) · Frontiers of Hormone Research · doi:10.1159/000115363 · Cited by 134
Tomlinson, J. W., Finney, J., Gay, C., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0495 · Cited by 131
Self-citationStanická, S., Vondra, K., Pelikánová, T., Vlček, P., Hill, M., & Zamrazil, V. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.121 · Cited by 129
11?-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
Stulnig, T. M., & Waldh�usl, W. (2004) · Diabetologia · doi:10.1007/s00125-003-1284-4 · Cited by 140
Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance
Asensio, C. S., Muzzin, P., & Rohner‐Jeanrenaud, F. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802856 · Cited by 150
From Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants
Pecoraro, N. C., Dallman, M. F., Warne, J. P., Ginsberg, A. B., Laugero, K. D., la Fleur, S. E., Houshyar, H., Gómez-Oliver, F., Bhargava, A., & Akana, S. F. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.004 · Cited by 144
Adipose tissue as an endocrine organ
Prins, J. B. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0222 · Cited by 121
Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases
Sandeep, T. C., & Walker, B. R. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00499-4 · Cited by 133
Kushnir, M. M., Neilson, R., Roberts, W. L., & Rockwood, A. L. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.01.005 · Cited by 129
A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease
Ahmed, A., Rabbitt, E., Brady, T., Brown, C., Guest, P., Bujalska, I. J., Doig, C., Newsome, P. N., Hubscher, S., Elias, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029531 · Cited by 115
“simple obesity, there is a reduction in the generation of serum cortisol from dexamethasone-suppressed values after the administration of oral cortisone reflecting decreased hepatic 11b-HSD1 activity [9].”
BackgroundSelf-citationPereira, C., Azevedo, I., Monteiro, R., & Martins, M. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01582.x · Cited by 126
Nair, S., Lee, Y. H., Lindsay, R. S., Walker, B. R., Tataranni, P. A., Bogardus, C., Baier, L. J., & Permana, P. A. (2004) · Diabetologia · doi:10.1007/s00125-004-1407-6 · Cited by 124
Splanchnic Cortisol Production Occurs in Humans
Basu, R., Singh, R. J., Basu, A., Chittilapilly, E. G., Johnson, C. M., Toffolo, G., Cobelli, C., & Rizza, R. A. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2051 · Cited by 111
McTernan, P. G. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1327 · Cited by 113
Self-citationCentral adiposity and cortisol responses to waking in middle-aged men and women
Steptoe, A., Kunz-Ebrecht, S., Brydon, L., & Wardle, J. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802715 · Cited by 118
Increased 5α-Reductase Activity and Adrenocortical Drive in Women with Polycystic Ovary Syndrome
Vassiliadi, D. A., Barber, T. M., Hughes, B. A., McCarthy, M. I., Wass, J. A. H., Franks, S., Nightingale, P., Tomlinson, J. W., Arlt, W., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0837 · Cited by 110
Self-citationCortisol and the metabolic syndrome in South Asians
Ward, A. M. V., Fall, C. H. D., Stein, C. E., Kumaran, K., Veena, S. R., Wood, P. J., Syddall, H. E., & Phillips, D. I. W. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01750.x · Cited by 108
Duclos, M., Gatta, B., Corcuff, J. ‐., Rashedi, M., Pehourcq, F., & Roger, P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01384.x · Cited by 105
11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
Wake, D. J., & Walker, B. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.015 · Cited by 124
Holmes, M. C., Carter, R. N., Noble, J., Chitnis, S., Dutia, A., Paterson, J. M., Mullins, J. J., Seckl, J. R., & Yau, J. L. W. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0731-10.2010 · Cited by 103
Exploring the pathogenesis of IIH: An inflammatory perspective
Sinclair, A. J., Ball, A. K., Burdon, M., Clarke, C. E., Stewart, P. M., Curnow, J., & Rauz, S. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.029 · Cited by 122
Self-citationModulation of glucocorticoid metabolism by the growth hormone – IGF‐1 axis
Agha, A., & Monson, J. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02763.x · Cited by 108
Sinclair, A. J., Walker, E. A., Burdon, M. A., van Beek, A. P., Kema, I. P., Hughes, B. A., Murray, P. I., Nightingale, P. G., Stewart, P. M., Rauz, S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0729 · Cited by 103
Self-citationHarrell, C. S., Burgado, J., Kelly, S. D., Johnson, Z. P., & Neigh, G. N. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.025 · Cited by 107
Cortisol Measures Across the Weight Spectrum
Schorr, M., Lawson, E. A., Dichtel, L. E., Klibanski, A., & Miller, K. K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2078 · Cited by 92
Growth Hormone, Insulin-Like Growth Factor-I and the Cortisol-Cortisone Shuttle
Stewart, P. M., Toogood, A. A., & Tomlinson, J. W. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048126 · Cited by 103
“There had been no explanation for this observation, but recent studies have shown that this increased clearance of F in obesity appears to be secondary to inhibition of 11β-HSD1 in the liver, as reflected by a reduction in the THF/THE ratio and impaired generation of circulating cortisol following an oral dose of cort…”
BackgroundSelf-citationHughes, K. A., Webster, S. P., & Walker, B. R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.481 · Cited by 102
The Contribution of Visceral Adipose Tissue to Splanchnic Cortisol Production in Healthy Humans
Andrew, R., Westerbacka, J., Wahren, J., Yki-Järvinen, H., & Walker, B. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1364 · Cited by 98
Beyond Obesity: The Diagnosis and Pathophysiology of Metabolic Syndrome
Gade, W., Schmit, J. M., Collins, M., & Gade, J. (2010) · American Society for Clinical Laboratory Science · doi:10.29074/ascls.23.1.51 · Cited by 120
Tomlinson, J. W., Sherlock, M., Hughes, B., Hughes, S. V., Kilvington, F., Bartlett, W., Courtney, R., Rejto, P., Carley, W., & Stewart, P. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2325 · Cited by 98
Self-citationSexual dimorphism in white and brown adipose tissue with obesity and inflammation
Bloor, I. D., & Symonds, M. E. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.02.007 · Cited by 108
Andrew, R., Smith, K., Jones, G. C., & Walker, B. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8157 · Cited by 91
11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone
Cooper, M. S., Blumsohn, A., Goddard, P. E., Bartlett, W. A., Shackleton, C. H., Eastell, R., Hewison, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-022025 · Cited by 96
Self-citation
Metadata
- Authors
- Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- National Health Service (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-03
- Volume
- 84
- Issue
- 3
- Pages
- 1022-1027
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2165935278
- Cited by
- 398
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 11 · 2019: 4 · 2018: 3 · 2017: 10 · 2016: 10 · 2015: 19 · 2014: 18 · 2013: 10 · 2012: 19
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- cortisol metabolism, abdominal obesity, cortisone to cortisol conversion, 11β-hydroxysteroid dehydrogenase type 1, urinary free cortisol, dexamethasone suppression, ACTH, body fat distribution, glucocorticoid metabolism, obesity pathogenesis, insulin resistance
- MeSH terms
- Adipose Tissue, Adult, Body Constitution, Cortisone, Female, Humans, Hydrocortisone, Male, Obesity, Tetrahydrocortisol, Tetrahydrocortisone, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.